- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0220525

Sparen Pharmachem LLP
About Sparen Pharmachem LLP
Data last updated:
Sparen Pharmachem LLP is a limited liability partnership (LLP) based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 March 2017 and has been in existence for over 9 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAI-8859. Its GSTIN is 24ADKFS0852M1ZR (Gujarat).
The LLP has a total obligation of contribution of βΉ1 Lakh. It is led by designated partners including Aashil Jayvant Patel and Saloni Aashil Patel.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at F Solitaire Park, Ahmedabad, Gujarat.
Sparen Pharmachem LLP is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0220525).
Company details
Recognitions & Rankings of Sparen Pharmachem
Contact details
Sparen Pharmachem LLP's registered office is in Ahmedabad, Gujarat.
- Registered AddressBlock B Office No. β 104 F/F Solitaire Park Nr. Divyabhaskar Press S. G. Highway M, Akarba, Ahmedabad, Gujarat, India β 380051
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sparen Pharmachem LLP
FY 2025 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | |||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | |||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Sparen Pharmachem LLP, buy the company report.
Designated partners of Sparen Pharmachem LLP
Sparen Pharmachem has 3 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aashil Jayvant Patel | Designated Partner | 21 Mar 2017 | 9 Years 7 Months | Current |
| Saloni Aashil Patel | Designated Partner | 21 Mar 2017 | 9 Years 7 Months | Current |
| Ajay Patwa Jaswantlal Also directs: Mahashakti Rasayan Pvt Ltd | Designated Partner | 21 Mar 2017 | 9 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Sparen Pharmachem LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sparen Pharmachem LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sparen Pharmachem has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24ADKFS0852M1ZR | Gujarat | Active | 14 Nov 2017 |
To see the full GST registrations and return filing status of Sparen Pharmachem LLP, buy the company report.
Recent activity
Sparen Pharmachem LLP has 3 designated partner changes on record since 2017: 3 appointments. The latest: Aashil Jayvant Patel was appointed as Designated Partner on 21 Mar 2017.
Frequently asked questions
Sparen Pharmachem is an active limited liability partnership based in Ahmedabad, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 21 March 2017 (9+ years old) and is registered under LLPIN AAI-8859.
Sparen Pharmachem has 3 current designated partners:
- Aashil Jayvant Patel - Designated Partner
- Saloni Aashil Patel - Designated Partner
- Ajay Patwa Jaswantlal - Designated Partner
The latest financial statements of Sparen Pharmachem on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Sparen Pharmachem is 24ADKFS0852M1ZR, registered in Gujarat.
The LLPIN (Limited Liability Partnership Identification Number) of Sparen Pharmachem is AAI-8859. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Sparen Pharmachem was incorporated on 21 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Aashil Jayvant Patel was appointed as Designated Partner on 21 Mar 2017. Ajay Patwa Jaswantlal was appointed as Designated Partner on 21 Mar 2017. Saloni Aashil Patel was appointed as Designated Partner on 21 Mar 2017.
Yes, Sparen Pharmachem is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0220525).
The registered office of Sparen Pharmachem is at Block B Office No. β 104 FF Solitaire Park Nr. Divyabhaskar Press S. G. Highway M, Akarba, Ahmedabad, Gujarat, India β 380051.
Sparen Pharmachem operates in the pharma industry, in the drug formulation and development segment.